You are here: Industry Insights > CDMO

News List

Curia to buy fellow CDMO Integrity Bio cphi-online
July 15, 2021
Acquisition will add West Coast coverage to the CDMO's East Coast and European capabilities and enhance its biologics formulation development and fill-finish network
Recro Pharma Inks Development and Mfg. Pact contractpharma
July 14, 2021
To support a client’s ongoing clinical development of an orally administered, minimally-absorbed investigational compound.
Hochuen Medical Raises Tens of Millions RMB in Series A Financing prnasia
July 13, 2021
Hochuen Medical Technology Co., Ltd. has raised a 40 million Yuan (RMB) Series A round of financing led by Qiming Venture Partners as the sole investor.
AMRI Becomes Curia contractpharma
July 13, 2021
Albany Molecular Research, Inc. (AMRI), a global contract research, development and manufacturing organization serving the pharmaceutical and biopharmaceutical industries, is changing its name to Curia, effective July 12, 2021.
LGM Pharma launches analytical and stability testing as standalone service cphi-online
July 13, 2021
LGM Pharma, a company offering integrated CDMO services, is launching its analytical services and facilities as a standalone contract service for drug developers and manufacturers.
Almac's Charnwood site achieves H&S and environmental certification prnewswire
July 12, 2021
The CDMO plans to roll out the ISO 45001 and ISO 14001 certification throughout multiple sites worldwide
LGM Pharma Launches Analytical Services for Drug Developers and Manufacturers contractpharma
July 09, 2021
LGM Pharma has launched its new Analytical Services offering that provides analytical testing and stability services to pharmaceutical developers and manufacturers, including compounding pharmacies.
Recipharm to Build New Fill-Finish Facility in Morocco contractpharma
July 07, 2021
Investment of around $500M by the Moroccan Government to establish capacity and capability for the manufacturing of vaccines and biotherapeutics.
Recipharm selected to operate new fill/finish facility in Morocco cphi-online
July 07, 2021
Move is part of US$500 million five-year investment programme by Moroccan government and consortium to establish vaccine and biotherapeutic manufacturing capacity in the country
CPhI Webinar: How is M&A Shifting the Pharma Manufacturing Landscape? cphi-online
July 07, 2021
The broad scope of the pharmaceutical manufacturing landscape is making merger and acquisition activity in the sector ever more complex with several varying factors driving decisions, according to a recent CPhI Webinar sponsored by PharmaVentures.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page